Investigators at Wake Forest School of Medicine, part of Wake Forest Baptist Health, have identified a set of new genetic markers that could potentially lead to new personalized treatments for lung cancer.
Brazil is heading toward unimaginable loss of lives, researchers warn
From CNN s Maggie Fox
The remains of a woman who died from complications related to Covid-19 are placed into a niche by cemetery workers and relatives at the Inahuma cemetery in Rio de Janeiro, Brazil on April 13. Silvia Izquierdo/AP
Brazil is reporting some of the world s highest new cases per day and the country may be headed for even worse times thanks to a combination of political chaos and inaction, a team of public health experts said on Wednesday.
“In Brazil, the federal response has been a dangerous combination of inaction and wrongdoing, including the promotion of chloroquine as treatment despite a lack of evidence,” wrote the team in their report, published in the journal Science.
Indian capital to convert banquet halls and hotels into Covid treatment facilities
From CNN s Manveena Suri in New Delhi
Health workers take care of Covid-19 patients at Shehnai banquet hall, which has been converted into a Covid care center in New Delhi, India on April 13. Mohd Zakir/Hindustan Times/Getty Images
Banquet halls and hotels in the Indian capital region of Delhi are being converted into “extended Covid hospitals” as cases continue to surge during the country s second wave.
A total of 23 hotels and banquets halls will be linked to private hospitals to add more than 2,000 additional beds, according to an order by Delhi Health Minister Satyendar Jain on Wednesday. Patients will be sent to the hotels and linked private hospitals depending on their condition.
Search jobs 15-Apr-2021 HUMMINGBIRD BIOSCIENCE PRESENTS PRE-CLINICAL DATA ON ITS NEXT-GENERATION BCMA-TACI DUAL-SPECIFIC T CELL ENGAGER AT 2021 AACR ANNUAL MEETING
HUMMINGBIRD BIOSCIENCE
2021 AACR ANNUAL MEETING
Singapore, April 10, 2021 – Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets to improve treatment outcomes, today announced that the company will be presenting pre-clinical data on its BCMA-TACI dual-specific T cell engager, HMBD-009, at the 2021 American Association for Cancer Research (AACR) Annual Meeting taking place 9-14 April.
HMBD-009 is Hummingbird’s next-generation T cell program that uniquely targets both B cell maturation antigen (BCMA) and Transmembrane activator and CAML Interactor (TACI), proteins commonly overexpressed in multiple myeloma, the second most common hematologic malignancy and a leading cause
AACR: Single-cell analysis transforming cancer research biopharma-reporter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharma-reporter.com Daily Mail and Mail on Sunday newspapers.